tradingkey.logo
tradingkey.logo
Search

Stocks Quotes

Stock quotes focus on the U.S. market data, including indices, sectors, and related U.S. equity instruments.
US30
US30
US30
51766.200+0.08%
SPX500
SPX500
US500
7413.300-0.09%
NAS100
NAS100
NAS100
28430.800-0.52%

Distribution

Latest
History
No Data

Sector

View More

Industrial Goods

+2.80%
Lockheed Martin Corp+10.41%
Unusual Machines Inc+9.71%
Rectitude Holdings Ltd+9.24%

Investment Holding Companies

+1.21%
SUNB.NB+6.96%
Miluna Acquisition Units+6.48%
Inflection Point Acquisition IV Ord Shs Class A+5.70%

Pharmaceuticals & Medical Research

+1.13%
Zhengye Biotechnology Holding Ltd+27.69%
Neuphoria Therapeutics Inc+16.82%
Scisparc Ltd+16.22%

Energy - Fossil Fuels

+1.03%
Vivakor Inc+28.22%
Robin Energy Ltd+26.91%
TMD Energy Ltd+18.60%

Utilities

+0.99%
Sunation Energy Inc+10.17%
SolarMax Technology Inc+6.33%
Ge Vernova Inc+4.83%

Healthcare Services & Equipment

+0.91%
Advanced Biomed Inc+36.49%
Novocure Ltd+28.39%
Acme United Corp+13.57%
No.
Name
Price
Change
Chg %
Total Score
Time
Volume
Turnover
Market Cap
Shares
Amplitude
Volume Ratio
52wk High
52wk Low
Dividends
Div Yield
5D
10D
20D
60D
120D
250D
Year to Date
Watchlist
4051
Jack in the Box Inc
Jack in the Box Inc
JACK
13.790
-0.450
-3.16%
7.01
687.34K
6.28M
262.78M
19.06M
5.61
1.03
25.340
8.915
0.00
0.00
-15.09%
-9.10%
+3.30%
+4.47%
-33.03%
-41.81%
-27.23%
4052
Treace Medical Concepts Inc
Treace Medical Concepts Inc
TMCI
4.055
+0.085
+2.14%
5.73
272.70K
782.12K
262.71M
64.79M
5.28
0.79
7.780
1.170
0.00
0.00
-8.47%
-12.98%
-1.82%
+111.20%
+76.30%
-29.97%
+65.51%
4053
Coeptis Therapeutics Holdings Inc
Coeptis Therapeutics Holdings Inc
COEP
16.400
0.000
0.00%
5.16
0.00
0.00
262.62M
5.16M
8.63
1.07
21.410
6.260
0.00
0.00
+5.53%
+35.54%
+53.56%
+20.50%
+7.75%
+82.83%
--
4054
TriSalus Life Sciences Inc
TriSalus Life Sciences Inc
TLSI
4.275
+0.035
+0.83%
5.92
262.04K
865.02K
262.55M
61.41M
6.83
1.39
7.950
2.200
0.00
0.00
-1.95%
+9.90%
+2.76%
-5.00%
-14.33%
-8.46%
-38.75%
4055
FB Bancorp Inc
FB Bancorp Inc
FBLA
15.430
-0.090
-0.58%
4.88
45.62K
544.42K
262.54M
17.02M
1.48
0.69
14.290
10.710
0.00
0.00
+0.52%
+2.25%
+3.35%
+9.82%
+19.15%
+28.26%
+20.08%
4056
HomeStreet Inc
HomeStreet Inc
HMST
13.870
0.000
0.00%
6.31
0.00
0.00
262.43M
18.92M
3.92
1.00
16.100
8.410
0.00
0.00
-0.93%
+5.40%
+6.28%
+8.36%
+61.09%
-10.52%
+21.45%
4057
2Seventy Bio Inc
2Seventy Bio Inc
TSVT
5.000
0.000
0.00%
--
0.00
0.00
262.32M
52.47M
0.40
1.07
5.300
2.290
0.00
0.00
+0.00%
+0.20%
+0.81%
--
--
--
--
4058
Clearwater Paper Corp
Clearwater Paper Corp
CLW
16.340
-0.290
-1.74%
6.30
155.21K
1.12M
262.07M
16.04M
3.42
0.70
30.960
11.730
0.00
0.00
+0.25%
+6.17%
-2.85%
+11.76%
-4.89%
-45.33%
-6.09%
4059
Sol Gel Technologies Ltd
Sol Gel Technologies Ltd
SLGL
80.060
-4.240
-5.03%
6.05
30.82K
1.06M
261.72M
3.27M
8.10
0.47
97.970
6.800
0.00
0.00
+2.54%
+4.85%
+9.07%
+3.97%
+31.57%
+620.61%
+89.99%
4060
M3-Brigade Acquisition V Corp
M3-Brigade Acquisition V Corp
MBAVU
11.020
0.000
0.00%
--
0.00
0.00
261.57M
0.00
1.08
1.56
16.780
10.200
0.00
0.00
+0.82%
+1.94%
+0.18%
+4.44%
+6.47%
-7.39%
--
4061
M3-Brigade Acquisition V Corp
M3-Brigade Acquisition V Corp
MBAV
10.870
0.000
0.00%
--
0.00
0.00
261.57M
35.94M
2.06
0.54
13.730
10.480
0.00
0.00
-0.09%
+0.28%
+0.18%
+0.72%
+1.87%
+2.16%
+2.26%
4062
Icecure Medical Ltd
Icecure Medical Ltd
ICCM
3.220
-0.110
-3.30%
6.28
97.38K
210.90K
261.40M
81.18M
4.80
1.13
1.400
0.215
0.00
0.00
-12.02%
-17.22%
-65.38%
+1033.80%
+422.73%
+226.90%
+427.78%
4063
First National Corp
First National Corp
FXNC
28.880
-0.150
-0.52%
5.73
42.08K
703.85K
261.10M
9.04M
11.35
1.02
29.850
18.310
0.65
2.25
-4.87%
-1.47%
-3.57%
+2.16%
+12.11%
+32.84%
+14.42%
4064
Torrid Holdings Inc
Torrid Holdings Inc
CURV
2.370
-0.010
-0.42%
6.52
171.24K
170.96K
260.70M
110.00M
3.74
0.61
5.535
0.939
0.00
0.00
+6.28%
+21.54%
+12.86%
+33.15%
+104.31%
-12.22%
+142.23%
4065
Kingsway Financial Services Inc
Kingsway Financial Services Inc
KFS
10.730
0.000
0.00%
4.83
0.00
0.00
260.23M
28.63M
1.85
1.01
16.795
9.840
0.00
0.00
-6.53%
+4.68%
-9.07%
-13.95%
-16.82%
+3.17%
-20.22%
4066
Hawthorn Bancshares Inc
Hawthorn Bancshares Inc
HWBK
37.640
+0.770
+2.09%
3.69
26.04K
831.34K
259.94M
6.91M
5.50
1.75
37.300
27.070
0.81
2.15
-6.11%
-1.65%
-4.39%
+10.74%
+10.71%
+30.60%
+7.91%
4067
Beyond Meat Inc
Beyond Meat Inc
BYND
0.561
-0.035
-5.93%
5.45
43.07M
19.75M
259.90M
463.20M
7.32
1.68
7.690
0.500
0.00
0.00
-6.53%
-16.84%
-17.69%
-38.30%
-27.70%
-85.43%
-31.57%
4068
Drugs Made In America Acquisition Corp
Drugs Made In America Acquisition Corp
DMAAU
10.970
0.000
0.00%
--
0.00
0.00
259.76M
0.00
0.00
0.00
10.604
10.000
0.00
0.00
+2.52%
+1.79%
+2.31%
+2.08%
+3.98%
+5.08%
+4.38%
4069
Chijet Motor Co Inc
Chijet Motor Co Inc
CJET
0.870
0.000
0.00%
0.66
0.00
0.00
259.46M
324.88K
9.74
1.92
299.000
0.820
0.00
0.00
-13.00%
-27.50%
-64.05%
+656.52%
-46.13%
-58.77%
-62.50%
4070
Montauk Renewables Inc
Montauk Renewables Inc
MNTK
1.810
+0.060
+3.43%
6.02
312.20K
361.58K
259.27M
143.24M
8.49
1.57
2.780
1.070
0.00
0.00
+7.10%
+16.03%
+16.03%
+30.22%
+16.77%
-27.02%
+8.38%
4071
Newbury Street II Acquisition Corp
Newbury Street II Acquisition Corp
NTWOU
10.780
0.000
0.00%
--
0.00
0.00
259.01M
0.00
0.00
0.61
10.990
10.260
0.00
0.00
--
--
+6.03%
--
--
+3.65%
--
4072
Newbury Street II Acquisition Corp
Newbury Street II Acquisition Corp
NTWO
10.715
-0.025
-0.23%
--
3.00
32.00
259.01M
24.12M
0.00
0.02
10.540
10.060
0.00
0.00
+0.23%
-0.14%
+0.66%
+1.37%
+2.14%
+3.68%
+2.73%
4073
FACT II Acquisition Corp
FACT II Acquisition Corp
FACTU
10.820
-0.010
-0.09%
--
492.00
11.00
258.78M
0.00
0.00
3.04
12.010
10.200
0.00
0.00
-8.58%
+1.94%
-9.08%
+1.03%
+1.03%
+5.05%
--
4074
FACT II Acquisition Corp
FACT II Acquisition Corp
FACT
10.640
0.000
0.00%
--
2.75K
11.99K
258.78M
24.32M
0.09
0.01
10.750
10.170
0.00
0.00
+0.09%
-0.28%
-0.09%
+0.57%
+1.14%
+3.70%
+2.21%
4075
AudioCodes Ltd
AudioCodes Ltd
AUDC
9.550
+0.110
+1.17%
6.23
74.56K
445.86K
258.70M
27.09M
1.80
0.89
11.500
6.950
0.30
3.14
-1.85%
-4.88%
+4.71%
+7.67%
+13.02%
-6.65%
+9.39%
4076
Outbrain Inc
Outbrain Inc
OB
2.740
0.000
0.00%
--
0.00
0.00
258.36M
94.29M
7.06
1.48
7.870
2.420
0.00
0.00
+8.30%
+4.58%
-20.69%
-32.01%
-58.04%
-40.04%
-61.84%
4077
Quantum Leap Acquisition Ord Shs Class A
Quantum Leap Acquisition Ord Shs Class A
QLEP
9.970
+0.010
+0.10%
--
33.38K
120.75K
258.29M
25.91M
0.10
1.61
9.980
9.930
0.00
0.00
+0.10%
+0.40%
+0.30%
--
--
--
--
4078
908 Devices Inc.
908 Devices Inc.
MASS
7.105
-0.135
-1.86%
7.15
252.99K
1.34M
258.07M
36.32M
5.38
0.93
9.340
5.025
0.00
0.00
-4.12%
-12.61%
-20.79%
+5.42%
+11.89%
-3.73%
+35.33%
4079
Inozyme Pharma Inc
Inozyme Pharma Inc
INZY
4.000
0.000
0.00%
--
0.00
0.00
257.88M
64.47M
0.25
0.87
6.240
0.721
0.00
0.00
+0.25%
+0.25%
+0.76%
+331.78%
+30.29%
-9.50%
+44.40%
4080
TechTarget Inc
TechTarget Inc
TTGT
3.565
-0.025
-0.70%
5.79
466.81K
1.30M
257.74M
72.30M
2.78
1.20
9.000
3.410
0.00
0.00
-4.68%
-5.44%
-3.65%
-36.90%
-33.24%
-59.02%
-33.98%

Stock Analysis

Intel Q2 Earnings Far Exceed Expectations: 59% Data Center Business Growth, CPUs Becoming AI Era Protagonists Again

TradingKey - As the market continues to question whether Intel (INTC) can truly ride the AI wave, the company’s second-quarter results have provided an answer. After market close on July 23 ET, Intel released its Q2 2026 earnings report, with revenue, earnings, and next-quarter guidance all significantly exceeding Wall Street's previous expectations.

TradingKey2 hours ago
TradingKey - As the market continues to question whether Intel (INTC) can truly ride the AI wave, the company’s second-quarter results have provided an answer. After market close on July 23 ET, Intel released its Q2 2026 earnings report, with revenue, earnings, and next-quarter guidance all significantly exceeding Wall Street's previous expectations.

NovoCure (NVCR) Breaks Out on Q2 2026 Earnings - Optune Pax Driving Recovery

TradingKey - NovoCure surged to $19.91 after Q2 2026 earnings released this morning. Revenue consensus was $172M growing 8.6% YoY. The story is Optune Pax's FDA approval and multi-indication expansion after June's TRIDENT trial disappointment. Here is the setup.

TradingKey4 hours ago
TradingKey - NovoCure surged to $19.91 after Q2 2026 earnings released this morning. Revenue consensus was $172M growing 8.6% YoY. The story is Optune Pax's FDA approval and multi-indication expansion after June's TRIDENT trial disappointment. Here is the setup.

Micron (MU) Hits $1,000 on Three Catalysts - Google Capex, Vera Rubin, NAND Shortage

TradingKey - Micron rose 4% to $1,000 on Thursday driven by Google and Tesla's massive AI capex confirming memory demand, Nvidia's Vera Rubin boosting HBM requirements, and TrendForce flagging a NAND shortage. At $996, $992 resistance has been cleared.

TradingKey5 hours ago
TradingKey - Micron rose 4% to $1,000 on Thursday driven by Google and Tesla's massive AI capex confirming memory demand, Nvidia's Vera Rubin boosting HBM requirements, and TrendForce flagging a NAND shortage. At $996, $992 resistance has been cleared.

Japan and South Korea Stocks Open Lower, KOSPI Drops Over 3%, SoftBank Falls Over 5%, SK Hynix and Kioxia Fall Nearly 4%

TradingKey - In early Asian trading on July 24, Japanese and South Korean stock markets opened lower and continued to decline. Influenced by the sharp overnight pullback in US stocks and escalating geopolitical risks in the Middle East, market risk-off sentiment has risen markedly.

TradingKey5 hours ago
TradingKey - In early Asian trading on July 24, Japanese and South Korean stock markets opened lower and continued to decline. Influenced by the sharp overnight pullback in US stocks and escalating geopolitical risks in the Middle East, market risk-off sentiment has risen markedly.

Today’s Market Recap: Oil Breaks $100, Fueling Inflation Fears, as AI Capex Faces Scrutiny and Tesla’s 14% Plunge Drags Down Tech Sector

TradingKey - The market was hit by a double whammy of soaring oil prices and doubts about the return on AI investments sparked by increased capital expenditures at Google(GOOGL) and Tesla(TSLA). The three major U.S. stock indices plummeted. At the close, the Dow Jones Industrial Average fell 0.97% t

TradingKey5 hours ago
TradingKey - The market was hit by a double whammy of soaring oil prices and doubts about the return on AI investments sparked by increased capital expenditures at Google(GOOGL) and Tesla(TSLA). The three major U.S. stock indices plummeted. At the close, the Dow Jones Industrial Average fell 0.97% t

Intel Q2 Net Profit Swings to Profit YoY, Adjusted EPS Doubles Estimates: Revenue Up 25%, After-Hours Shares Rise Over 13%

Intel (INTC) released its second-quarter 2026 financial results after the U.S. market close on July 23, Eastern Time. As of press time, the stock rose 12.44% to $112.7. During the period, Intel's revenue increased by 25% year-on-year to $16.128 billion, significantly exceeding the market expectation of $14.42 billion by approximately 12%. CEO Lip-Bu Tan stated that this marked the company's strongest quarterly revenue growth in over fifteen years, driven by increased speed, stronger execution, and customer focus.

TradingKey9 hours ago
Intel (INTC) released its second-quarter 2026 financial results after the U.S. market close on July 23, Eastern Time. As of press time, the stock rose 12.44% to $112.7. During the period, Intel's revenue increased by 25% year-on-year to $16.128 billion, significantly exceeding the market expectation of $14.42 billion by approximately 12%. CEO Lip-Bu Tan stated that this marked the company's strongest quarterly revenue growth in over fifteen years, driven by increased speed, stronger execution, and customer focus.

TradingKey SmartPicks

Upcoming Events

Earnings

Dividends

Stock Splits

IPO

Market Heatmap

Stocks

Sector

tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.